View in EDS

Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).

Saved in:
Bibliographic Details
Title: Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).
Authors: Filipski KJ; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Sammons MF; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Bhattacharya SK; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Panteleev J; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Brown JA; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Loria PM; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Boehm M; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Smith AC; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Shavnya A; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Conn EL; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States., Song K; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Weng Y; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Facemire C; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States., Jüppner H; Endocrine Unit and Pediatric Nephrology Unit, Thier 10, Massachusetts General Hospital and Harvard Medical School, 50 Blossom Street, Boston, Massachusetts 02114, United States., Clerin V; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Apr 12; Vol. 9 (5), pp. 440-445. Date of Electronic Publication: 2018 Apr 12 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29795756
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Filipski+KJ%22">Filipski KJ</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Sammons+MF%22">Sammons MF</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+SK%22">Bhattacharya SK</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Panteleev+J%22">Panteleev J</searchLink>; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Brown+JA%22">Brown JA</searchLink>; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Loria+PM%22">Loria PM</searchLink>; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Boehm+M%22">Boehm M</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Smith+AC%22">Smith AC</searchLink>; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Shavnya+A%22">Shavnya A</searchLink>; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Conn+EL%22">Conn EL</searchLink>; Pfizer Worldwide Research & Development, 558 Eastern Point Road, Groton, Connecticut 06340, United States.<br /><searchLink fieldCode="AU" term="%22Song+K%22">Song K</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Weng+Y%22">Weng Y</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Facemire+C%22">Facemire C</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.<br /><searchLink fieldCode="AU" term="%22Jüppner+H%22">Jüppner H</searchLink>; Endocrine Unit and Pediatric Nephrology Unit, Thier 10, Massachusetts General Hospital and Harvard Medical School, 50 Blossom Street, Boston, Massachusetts 02114, United States.<br /><searchLink fieldCode="AU" term="%22Clerin+V%22">Clerin V</searchLink>; Pfizer Worldwide Research & Development, 1 Portland Street, Cambridge, Massachusetts 02139, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101521073%22">ACS medicinal chemistry letters</searchLink> [ACS Med Chem Lett] 2018 Apr 12; Vol. 9 (5), pp. 440-445. <i>Date of Electronic Publication: </i>2018 Apr 12 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101521073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1948-5875 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219485875%22">19485875 </searchLink><i>NLM ISO Abbreviation: </i>ACS Med Chem Lett <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29795756
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acsmedchemlett.8b00013
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 440
    Titles:
      – TitleFull: Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Filipski KJ
      – PersonEntity:
          Name:
            NameFull: Sammons MF
      – PersonEntity:
          Name:
            NameFull: Bhattacharya SK
      – PersonEntity:
          Name:
            NameFull: Panteleev J
      – PersonEntity:
          Name:
            NameFull: Brown JA
      – PersonEntity:
          Name:
            NameFull: Loria PM
      – PersonEntity:
          Name:
            NameFull: Boehm M
      – PersonEntity:
          Name:
            NameFull: Smith AC
      – PersonEntity:
          Name:
            NameFull: Shavnya A
      – PersonEntity:
          Name:
            NameFull: Conn EL
      – PersonEntity:
          Name:
            NameFull: Song K
      – PersonEntity:
          Name:
            NameFull: Weng Y
      – PersonEntity:
          Name:
            NameFull: Facemire C
      – PersonEntity:
          Name:
            NameFull: Jüppner H
      – PersonEntity:
          Name:
            NameFull: Clerin V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 04
              Text: 2018 Apr 12
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 1948-5875
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: ACS medicinal chemistry letters
              Type: main
ResultId 1